Retrospective analysis of HHV-8 viremia and cellular viral load in HIV-seropositive patients receiving interleukin 2 in combination with antiretroviral therapy
Mauro Malnati(Vita-Salute San Raffaele University), Giuseppe Tambussi(San Raffaele University of Rome), Loredana Sarmati(University of Rome Tor Vergata), Adriano Lazzarin(Vita-Salute San Raffaele University), Paolo Monini(Istituto Superiore di Sanità), Paolo Lusso(National Institute of Allergy and Infectious Diseases), Brunella Capiluppi(Vita-Salute San Raffaele University), Francesco Broccolo(University of Salento), Massimo Andreoni(University of Rome Tor Vergata), Silvia Nozza(IRCCS Ospedale San Raffaele), A. Careddu, Giuseppe Locatelli(University of L'Aquila), Silvia Ghezzi(Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda), Fanny Delfanti(University of Rome Tor Vergata), Guido Poli(University of Verona)
Cited by 13
Related Papers
Monkeypox Virus Infection in Humans across 16 Countries — April–June 2022
|New England Journal of Medicine|2022|2.2k
Dual-targeted therapy with trastuzumab and lapatinib in treatment-refractory, KRAS codon 12/13 wild-type, HER2-positive metastatic colorectal cancer (HERACLES): a proof-of-concept, multicentre, open-label, phase 2 trial
|The Lancet Oncology|2016|1k
Efficacy of Enfuvirtide in Patients Infected with Drug-Resistant HIV-1 in Europe and Australia
|New England Journal of Medicine|2003|653
In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression
|Nature Medicine|1997|635